These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 33764480)
1. Role of Multidisciplinary Care in the Management of Hepatocellular Carcinoma. Byrd K; Alqahtani S; Yopp AC; Singal AG Semin Liver Dis; 2021 Jan; 41(1):1-8. PubMed ID: 33764480 [TBL] [Abstract][Full Text] [Related]
2. Multidisciplinary Approach to HCC Management: How Can This Be Done? Gadsden MM; Kaplan DE Dig Dis Sci; 2019 Apr; 64(4):968-975. PubMed ID: 30887152 [TBL] [Abstract][Full Text] [Related]
3. A narrative review of supportive and end of life care considerations in advanced hepatocellular carcinoma. Hashmi IN; Lee HM; Wedd JP; Sterling RK; Dulong-Rae TE; Cassel JB; Cyrus JW; Fletcher JJ; Noreika DM Ann Palliat Med; 2023 Nov; 12(6):1260-1274. PubMed ID: 37691333 [TBL] [Abstract][Full Text] [Related]
4. Contrasting Some Differences in Managing Advanced Unresectable Hepatocellular Carcinoma Between the East and the West. Lee VHF; Seong J; Yoon SM; Wong TCL; Wang B; Zhang JL; Chiang CL; Ho PPY; Dawson LA Clin Oncol (R Coll Radiol); 2019 Aug; 31(8):560-569. PubMed ID: 31279433 [TBL] [Abstract][Full Text] [Related]
5. Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment. Yegin EG; Oymaci E; Karatay E; Coker A Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):234-56. PubMed ID: 27298100 [TBL] [Abstract][Full Text] [Related]
6. Shaping the future management of hepatocellular carcinoma. Abou-Alfa G; Colombo M Semin Liver Dis; 2013 Feb; 33 Suppl 1():S20-3. PubMed ID: 23457036 [TBL] [Abstract][Full Text] [Related]
7. Advances in Local and Systemic Therapies for Hepatocellular Cancer. Mokdad AA; Singal AG; Yopp AC Curr Oncol Rep; 2016 Feb; 18(2):9. PubMed ID: 26769114 [TBL] [Abstract][Full Text] [Related]
8. Multidisciplinary Team Management of Hepatocellular Carcinoma Is Standard of Care. Lhewa D; Green EW; Naugler WE Clin Liver Dis; 2020 Nov; 24(4):771-787. PubMed ID: 33012458 [TBL] [Abstract][Full Text] [Related]
9. Management of patients with hepatocellular carcinoma and extrahepatic metastasis. Lee HS Dig Dis; 2011; 29(3):333-8. PubMed ID: 21829026 [TBL] [Abstract][Full Text] [Related]
10. Medical Management of Hepatocellular Carcinoma. Rich NE; Yopp AC; Singal AG J Oncol Pract; 2017 Jun; 13(6):356-364. PubMed ID: 28605614 [TBL] [Abstract][Full Text] [Related]
11. [Personalized healthcare in hepatocellular carcinoma. Multi-society Italian position paper.]. Trevisani F; Garuti F; Neri A Recenti Prog Med; 2018 Jan; 109(1):38-45. PubMed ID: 29451521 [TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma (HCC): current and evolving therapies. Gish RG; Baron A IDrugs; 2008 Mar; 11(3):198-203. PubMed ID: 18311657 [TBL] [Abstract][Full Text] [Related]
13. Survival and prognostic factors for hepatocellular carcinoma: an Egyptian multidisciplinary clinic experience. Abdelaziz AO; Elbaz TM; Shousha HI; Ibrahim MM; Rahman El-Shazli MA; Abdelmaksoud AH; Aziz OA; Zaki HA; Elattar IA; Nabeel MM Asian Pac J Cancer Prev; 2014; 15(9):3915-20. PubMed ID: 24935574 [TBL] [Abstract][Full Text] [Related]
14. Symptom management in hepatocellular carcinoma. Sun VC; Sarna L Clin J Oncol Nurs; 2008 Oct; 12(5):759-66. PubMed ID: 18842532 [TBL] [Abstract][Full Text] [Related]
15. A Review and Update of Treatment Options and Controversies in the Management of Hepatocellular Carcinoma. Dhir M; Melin AA; Douaiher J; Lin C; Zhen WK; Hussain SM; Geschwind JF; Doyle MB; Abou-Alfa GK; Are C Ann Surg; 2016 Jun; 263(6):1112-25. PubMed ID: 26813914 [TBL] [Abstract][Full Text] [Related]
16. Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective. Colombo M; Raoul JL; Lencioni R; Galle PR; Zucman-Rossi J; Bañares R; Seehofer D; Neuhaus P; Johnson P Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):639-51. PubMed ID: 23628963 [TBL] [Abstract][Full Text] [Related]
17. Increased multimodality treatment options has improved survival for Hepatocellular carcinoma but poor survival for biliary tract cancers remains unchanged. Alabraba E; Joshi H; Bird N; Griffin R; Sturgess R; Stern N; Sieberhagen C; Cross T; Camenzuli A; Davis R; Evans J; O'Grady E; Palmer D; Diaz-Nieto R; Fenwick S; Poston G; Malik H Eur J Surg Oncol; 2019 Sep; 45(9):1660-1667. PubMed ID: 31014988 [TBL] [Abstract][Full Text] [Related]